Patents by Inventor Andrea Müller

Andrea Müller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11151408
    Abstract: An occlusion detection system to perform operations that include: capturing image data that depicts an environment at a client device, the environment including a target object at a position within the environment; causing display of a presentation of the environment at the client device, the presentation of the environment including a display of the target object at the position within the environment; detecting a first attribute of the display of the target object at the client device; performing a comparison of the first attribute of the display of the target object and a second attribute associated with the target object; and detecting an occlusion based on the comparison.
    Type: Grant
    Filed: September 10, 2019
    Date of Patent: October 19, 2021
    Assignee: Snap Inc.
    Inventors: Piers Cowburn, David Li, Isac Andreas Müller Sandvik, Qi Pan
  • Publication number: 20210318007
    Abstract: A filter device for filtering particles from an air flow has an inlet channel through which the air to be cleaned flows, at least one filter element through which the air can flow and which is held replaceably in a flow channel, and an outlet channel through which the cleaned air flows. The filter device has an insertion chamber which can be closed by a door and from which a filter element can be fed to the flow channel, and an output chamber which can be closed by a closure element and into which a filter element can be fed from the flow channel. A cover is attachable to the filter element, which covers a filter cake on the filter element so that the unit of filter element and cover is removable from the output chamber together.
    Type: Application
    Filed: April 8, 2021
    Publication date: October 14, 2021
    Applicants: Lufttechnik Gransee GmbH, Oerlikon Textile GmbH & Co KG
    Inventors: Rainer MATHO, Andreas MUELLER, Stephan RICKERTS, Ernst CLAUSSEN, Hauke PETERSEN, Frank KNOEDLER, Sonja DITTSCHER
  • Publication number: 20210316918
    Abstract: The invention relates to containers for the drying, especially the freeze-drying, of material. In particular, the invention relates to a lid of a drying container, said lid enabling to close the container body of the drying container so as to avoid i) contamination of the material to be dried inside the container and ii) spills of airborne solid particles of said material from the container to the environment. The lid comprises a lower and an upper frame with a vapor permeable sheet positioned in between. The invention further provides methods for the drying, especially the freeze-drying, of material.
    Type: Application
    Filed: July 6, 2017
    Publication date: October 14, 2021
    Inventors: Andreas MUELLER, Christoph ERDIN
  • Publication number: 20210316244
    Abstract: A filter device for filtering particles from an air stream has an inlet channel through which the air to be purified flows, at least one filter element through which the air can flow and which is interchangeably held in a flow channel, and an outlet channel through which the purified air flows, an insertion chamber which can be closed by a door and from which a filter element can be fed to the flow channel, and an output chamber closable by a closure element, into which a filter element is feedable from the flow channel. The closure element of the output chamber is locked in the closed position via a locking mechanism when the door on the insertion chamber is opened and the output chamber and the insertion chamber are connected to the same flow channel.
    Type: Application
    Filed: April 8, 2021
    Publication date: October 14, 2021
    Applicants: Lufttechnik Gransee GmbH, Oerlikon Textile GmbH & Co KG
    Inventors: Rainer MATHO, Andreas MUELLER, Stephan RICKERTS, Ernst CLAUSSEN, Hauke PETERSEN, Frank KNOEDLER, Sonja DITTSCHER
  • Patent number: 11139335
    Abstract: The assembly comprises a semiconductor device with an active-pixel array, a readout circuit chip or plurality of readout circuit chips mounted outside the active-pixel array, the readout circuit chip or plurality of readout circuit chips being configured to read out voltages or currents provided by the active-pixel array, and electric connections between the active-pixel array and the readout circuit chip or plurality of readout circuit chips.
    Type: Grant
    Filed: July 26, 2018
    Date of Patent: October 5, 2021
    Assignee: AMS INTERNATIONAL AG
    Inventors: Thomas Froehlich, Michael Leitner, Thomas Troxler, Josef Pertl, Dominik Hollinger, Thomas Mueller, Andreas Fitzi, Jens Hofrichter
  • Publication number: 20210303859
    Abstract: An augmented reality system to perform operations that include: accessing image data at a client device; determining a position of a user of the client device based on the image data; causing display of a projection that extends from the position of the user upon a presentation of the image data at the client device; detecting an intersection of the projection and a surface of an object; generating a request that includes an identification of the portion of the surface of the object at the client device; and presenting the portion of the surface of the object based on the graphical property of the projection at the client device in response to the request that includes the identification of the portion of the surface of the object.
    Type: Application
    Filed: December 11, 2020
    Publication date: September 30, 2021
    Inventors: David Li, Isac Andreas Müller Sandvik, Qi Pan, Rastan Boroujerdi, Kevin Yimeng Hong, Peng Deng, Piers George Cowburn, Jonathan Tang, Junjie Wei
  • Publication number: 20210303075
    Abstract: Method of creating shared AR session based on a gesture starts with server receiving observed motion data from first device associated with first user. First device generating observed motion data based on an analysis of data stream comprising images of second user performing a gesture. Second user being associated with second device. Server receiving from second device captured motion data that corresponds to the gesture. Captured motion data being recorded by a sensor included in second device. Server determines whether there is a match between observed motion data from first device and captured motion data from second device. In response to determining that there is the match, server generates shared AR session between first device and second device and causes shared AR session to be displayed by first device and second device. Other embodiments are described herein.
    Type: Application
    Filed: August 3, 2020
    Publication date: September 30, 2021
    Inventors: Piers George Cowburn, David Li, Isac Andreas Müller Sandvik, Qi Pan
  • Patent number: 11130745
    Abstract: The present invention provides triazolone compounds of general formula (I): in which R1, R2, R3, R4 and R5 are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of hyperproliferative disorders, as a sole agent or in combination with other active ingredients.
    Type: Grant
    Filed: August 18, 2020
    Date of Patent: September 28, 2021
    Assignees: BAYER AKTIENGELLSCHAFT, BAYER PHARMA AKTIEGELLSCHAFT, THE BROAD INSTITUTE INC., PRESIDENT AND FELLOWS OF HARVARD COLLEGE, THE GENERAL HOSPITAL CORPORATION
    Inventors: Stefan Nikolaus Gradl, Duy Nguyen, Knut Eis, Judith Günther, Timo Stellfeld, Andreas Janzer, Sven Christian, Thomas Müller, Sherif El Sheikh, David B. Sykes, Steven James Ferrara, Michael Kröber, Claudia Merz, Michael Niehues, Martina Schäfer, Katja Zimmermann, Carl Friedrich Nising
  • Publication number: 20210290610
    Abstract: The invention provides pharmaceutical compositions comprising a farnesoid X receptor (FXR) agonist and another therapeutic agent, in particular for treating or preventing liver diseases or disorders.
    Type: Application
    Filed: September 12, 2017
    Publication date: September 23, 2021
    Inventors: Andreas BAUER, Bryan LAFFITTE, Patrick MUELLER
  • Publication number: 20210292286
    Abstract: The present invention provides an improved process for isolating 2,4-bis-(2,4-dihydroxyphenyl)-6-(4-methoxyphenyl)-1,3,5-triazine (DIOPAT) from an aqueous alkaline mixture M comprising the DIOPAT, 2,4-dihydroxybenzophenone, and aluminum salts, wherein the process comprises the steps of precipitating the DIOPAT by acidifying the mixture M to a pH<1; heating the acidified mixture M to a temperature in the range of from 80° C. to 95° C.; and separating of the precipitated DIOPAT from the dissolved 2,4-dihydroxybenzophenone and the dissolved aluminum salts with a ceramic membrane by means of diafiltration.
    Type: Application
    Filed: July 18, 2019
    Publication date: September 23, 2021
    Inventors: Jacek MALISZ, Andreas MUELLER, Johannes NAGEL, Dominik LANZINGER
  • Publication number: 20210294044
    Abstract: In a method for aligning a polarization-maintaining optical fiber, in which the optical fiber (7a, 7b, 7c) is held in clamping fashion by means of a clamping device (12, 19, 23), a given rotational position of the optical fiber (7a, 7b, 7c) about the fiber longitudinal axis is detected, and the optical fiber (7a, 7b, 7c) is rotated about the fiber longitudinal axis by means of the clamping device (12, 19, 23), it is proposed that at least one clamping element (13, 14, 20-22, 24-27) of the clamping device (12, 19, 23), said clamping element abutting against the optical fiber (7a, 7b, 7c), is moved relative to at least one further clamping element (13, 14, 20-22, 24-27) of the clamping device (12, 13, 17), said at least one further clamping element likewise abutting against the optical fiber (7a, 7b, 7c), for the purposes of rotating the optical fiber (7a, 7b, 7c). Moreover, a correspondingly configured apparatus is presented.
    Type: Application
    Filed: June 14, 2019
    Publication date: September 23, 2021
    Inventors: Sebastian Haag, Andrea Alippi, Tobias Müller, Daniel Zontar, Ronald Dekker
  • Patent number: 11128726
    Abstract: The disclosure relates to a method for communicating machine control data of a mechatronic system in a network having publisher and subscriber network users that send control data via the network using a data interchange standard that supports a publish/subscribe communication model. In order to make such a method simple, fast and robust, it is proposed that a machine controller of the mechatronic system can be configured indiscriminately as a subscriber or publisher network user to communicate the control data, As a publisher, the machine controller provides the control data with a message identifier, encodes them as a network message using the data interchange standard and sends the network message via the network. As subscriber, the machine controller receives a network message intended therefor using a message identifier via the network and decodes the network message as control data using the data interchange standard.
    Type: Grant
    Filed: September 20, 2019
    Date of Patent: September 21, 2021
    Assignee: Robert Bosch GmbH
    Inventors: Andreas Eckhardt, Sebastian Mueller
  • Publication number: 20210283230
    Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
    Type: Application
    Filed: May 14, 2021
    Publication date: September 16, 2021
    Inventors: Andrea MAHR, Toni WEINSCHENK, Oliver SCHOOR, Jens FRITSCHE, Harpreet SINGH, Phillip MUELLER, Julia LEIBOLD, Valentina GOLDFINGER
  • Publication number: 20210283105
    Abstract: The invention provides novel regimens of farnesoid X receptor (FXR) agonist and methods for modulating the activity of farnesoid X receptors (FXRs) using novel regimes of specific FXR agonists, in particular for treating or preventing fibrotic or cirrhotic diseases or disorders, such as liver diseases.
    Type: Application
    Filed: June 2, 2021
    Publication date: September 16, 2021
    Inventors: Michael BADMAN, Andreas BAUER, Jin CHEN, Bryan LAFFITTE, Patrick MUELLER, Rachel SOON
  • Publication number: 20210284842
    Abstract: A silicone composition including: at least two reactive polydiorganosiloxane polymers P1 and P2 that together account for 20% to 60% by weight, based on the overall silicone composition; at least one crosslinker for polydiorganosiloxanes, with a proportion of 0.5% to 5% by weight, based on the overall silicone composition; at least one catalyst, with a proportion of 0.001% to 0.1% by weight, based on the overall silicone composition; at least one optionally hydrophobized filler, selected from precipitated or fumed silica and ground or precipitated chalk, with a proportion of 10% to 70% by weight, based on the overall silicone composition, wherein the reactive polyorganosiloxane polymer P1 has a higher reactivity in the condensation crosslinking with the crosslinker than the reactive polyorganosiloxane polymer P2 and the molar ratio P1:P2 in the composition is between 0.1 and 15.
    Type: Application
    Filed: August 16, 2017
    Publication date: September 16, 2021
    Applicant: SIKA TECHNOLOGY AG
    Inventors: André SAVOY, Manuel FRIEDEL, Andrea MÜLLER
  • Patent number: 11117494
    Abstract: A locking unit (10), for a vehicle seat (1), includes a locking pawl (80) which is mounted so as to be pivotable about a pivot axis between an open position and a closed position and which has a retention contour (27) for securing a locking bolt (12) in the closed position. At least one claw (90, 91, 92), offset in the axial direction with respect to the locking pawl (80), is mounted so as to be pivotable about the same pivot axis. The claw (90, 91, 92) has a closure contour (25). The locking pawl (80) can be pivoted from the open position to the closed position by the closure contour (25) being acted upon by the locking bolt (12).
    Type: Grant
    Filed: March 7, 2016
    Date of Patent: September 14, 2021
    Assignee: Adient Luxembourg Holding S.à.r.l.
    Inventors: Andreas Vedder, Uwe Moeller, Igor Gordeenko, Oezkan Demirci, Patrick Handl, Silke Labuk, Christina Jungblut, Peter Mueller, Stefan Haber, Volker Windecker, Richard Haensel
  • Publication number: 20210275654
    Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor associated T-cell peptide epitopes, alone or in combination with other tumor associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
    Type: Application
    Filed: May 14, 2021
    Publication date: September 9, 2021
    Inventors: Andrea MAHR, Toni WEINSCHENK, Oliver SCHOOR, Jens FRITSCHE, Harpreet SINGH, Phillip MUELLER, Julia LEIBOLD, Valentina GOLDFINGER
  • Publication number: 20210275653
    Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
    Type: Application
    Filed: May 14, 2021
    Publication date: September 9, 2021
    Inventors: Andrea MAHR, Toni WEINSCHENK, Oliver SCHOOR, Jens FRITSCHE, Harpreet SINGH, Phillip MUELLER, Julia LEIBOLD, Valentina GOLDFINGER
  • Publication number: 20210279969
    Abstract: A crowd-sourced modeling system to perform operations that include: receiving image data that comprises image attributes; accessing a 3D model based on at least the image attributes of the image data, wherein the 3D model comprises a plurality of parts that collectively depict an object or environment; identifying a change in the object or environment based on a comparison of the image data with the plurality of parts of the 3D model, the change corresponding to a part of the 3D model from among the plurality of parts; and generating an update to the part of the 3D model based on the image attributes of the image data.
    Type: Application
    Filed: May 25, 2021
    Publication date: September 9, 2021
    Inventors: Piers Cowburn, Isac Andreas Müller Sandvik, Qi Pan, David Li
  • Publication number: 20210268089
    Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
    Type: Application
    Filed: April 30, 2021
    Publication date: September 2, 2021
    Inventors: Toni WEINSCHENK, Andrea MAHR, Jens FRITSCHE, Phillip MUELLER, Anita WIEBE, Sarah KUTSCHER